Intradermal triamcinolone treatment of psoriatic onychodystrophy.
Intradermal injections of triamcinolone acetonide have used in the treatment of psoriatic onychodystrophies in seven patients. The therapeutic response initially is good but relapses appear inevitable. One patient developed rather persistent periungual hypopigmentation, thereby limiting the routine recommendation of this form of treatment.
D000293:Adolescent; D000328:Adult; D001284:Atrophy; D002648:Child; D005260:Female; D006801:Humans; D007271:Injections, Intradermal; D008297:Male; D009262:Nails / Q000473:pathology*; D010859:Pigmentation Disorders / Q000139:chemically induced; D011565:Psoriasis / Q000188:drug therapy*; D012075:Remission, Spontaneous; D014222:Triamcinolone Acetonide / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D014222:Triamcinolone Acetonide